{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T12:25:42Z","timestamp":1758630342672},"reference-count":25,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2010,4,15]],"date-time":"2010-04-15T00:00:00Z","timestamp":1271289600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Transplantation"],"published-print":{"date-parts":[[2011,5]]},"abstract":"<jats:p>Abe T, Ichimaru N, Kakuta Y, Okumi M, Imamura R, Isaka Y, Takahara S, Kokado Y, Okuyama A. Long\u2010term outcome of pediatric renal transplantation: a single center experience.\u2028Clin Transplant 2011: 25: 388\u2013394. \u00a9 2010 John Wiley &amp; Sons A\/S.<\/jats:p><jats:p><jats:bold>Abstract:\u2002<\/jats:bold> Renal transplantation is the optimal treatment for pediatric end\u2010stage renal disease. We examined 51 children &lt;20\u2003yr old who underwent a total of 52 living\u2010donor renal transplantations at Osaka University Hospital between 1972 and 2004. The mean age at transplantation was 13.7 (3\u201319\u2003yr). The mean duration of follow\u2010up was 16.5\u2003yr. The five\u2010, 10\u2010, and 20\u2010yr patient survival rates following renal transplantation were 94%, 90%, and 87%, respectively. The five\u2010, 10\u2010, and 20\u2010yr graft survival rates were 76%, 65%, and 48%, respectively. A double\u2010drug regimen was used before 1987; this was replaced by a triple\u2010drug regimen including a calcineurin inhibitor in 1988. The five\u2010, 10\u2010, and 20\u2010yr graft survival rates after 1988 (89%, 80%, and 60%, respectively) were higher than those before 1987. Growth was examined among patients &lt;15\u2003yr old at the time of surgery, and height standard deviation (SD) scores (Z\u2010scores) were analyzed in 14 patients who displayed favorable renal function after transplantation. At the time of transplantation, mean SD score (SDS) was \u22122.39, and mean final adult SDS was \u22121.79. Rates of patient and graft survival after renal transplantation were mostly favorable. Future goals must include overcoming chronic rejection and establishing a steroid discontinuation protocol to improve growth.<\/jats:p>","DOI":"10.1111\/j.1399-0012.2010.01250.x","type":"journal-article","created":{"date-parts":[[2010,4,16]],"date-time":"2010-04-16T02:36:32Z","timestamp":1271385392000},"page":"388-394","source":"Crossref","is-referenced-by-count":8,"title":["Long\u2010term outcome of pediatric renal transplantation: a single center experience"],"prefix":"10.1111","volume":"25","author":[{"given":"Toyofumi","family":"Abe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naotsugu","family":"Ichimaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Kakuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"Okumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoichi","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Isaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Takahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukito","family":"Kokado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Okuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,6,8]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3046.2001.00003.x"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-006-0081-y"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031643"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200109270-00010"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/5.5.332"},{"key":"e_1_2_5_7_2","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1681\/ASN.V1291986","article-title":"The primary hyperoxaluria","volume":"12","author":"Leumann E","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_5_8_2","unstructured":"North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) Annual Report2006."},{"key":"e_1_2_5_9_2","unstructured":"North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) Annual Report2004.http:\/\/spitfire.emmes.com\/study\/ped\/resources\/annlrept2004.pdf"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004670100000"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200004150-00035"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3046.2004.00158.x"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3046.2002.00021.x"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.85.6.478"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00805.x"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199601150-00008"},{"key":"e_1_2_5_17_2","first-page":"29","article-title":"A prospective trial of steroid cessation after renal transplantation in pediatric patients treated with cyclosporine and mizoribine","volume":"1","author":"Motoyama O","year":"1997","journal-title":"Pediatr Transplant"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200009150-00008"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000133536.83756.1F"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(00)02054-6"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200107150-00011"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000092950.54184.67"},{"key":"e_1_2_5_23_2","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1681\/ASN.V1261297","article-title":"The growth hormone and insulin\u2010like growth factor axis: its manipulation for the benefit of growth disorders in renal failure","volume":"12","author":"Roelfsema V","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-004-1688-5"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000147785.11967.1D"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-002-0962-7"}],"container-title":["Clinical Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-0012.2010.01250.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-0012.2010.01250.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T14:37:21Z","timestamp":1697380641000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-0012.2010.01250.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["10.1111\/j.1399-0012.2010.01250.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-0012.2010.01250.x","archive":["Portico"],"relation":{},"ISSN":["0902-0063","1399-0012"],"issn-type":[{"value":"0902-0063","type":"print"},{"value":"1399-0012","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}